Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$78.68 - $90.67 $215,976 - $248,889
-2,745 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$71.69 - $91.23 $47.1 Million - $59.9 Million
-656,754 Reduced 99.58%
2,745 $250,000
Q3 2020

Nov 16, 2020

SELL
$67.19 - $87.44 $3.52 Million - $4.58 Million
-52,417 Reduced 7.36%
659,499 $52.6 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $21.4 Million - $28.7 Million
372,632 Added 109.83%
711,916 $49.2 Million
Q1 2020

May 15, 2020

SELL
$52.41 - $81.0 $30.5 Million - $47.1 Million
-581,502 Reduced 63.15%
339,284 $64 Million
Q4 2019

Feb 14, 2020

SELL
$71.7 - $82.09 $35.2 Million - $40.3 Million
-491,493 Reduced 34.8%
920,786 $215 Million
Q3 2019

Nov 15, 2019

SELL
$61.55 - $75.43 $21.2 Million - $26 Million
-344,516 Reduced 19.61%
1,412,279 $311 Million
Q2 2019

Aug 14, 2019

SELL
$55.74 - $64.41 $5.41 Million - $6.25 Million
-97,037 Reduced 5.23%
1,756,795 $325 Million
Q1 2019

May 14, 2019

SELL
$47.89 - $64.05 $2.93 Million - $3.92 Million
-61,279 Reduced 3.2%
1,853,832 $355 Million
Q4 2018

Feb 13, 2019

SELL
$46.41 - $56.94 $6.9 Million - $8.46 Million
-148,593 Reduced 7.2%
1,915,111 $293 Million
Q3 2018

Nov 16, 2018

BUY
$45.7 - $58.03 $1.66 Million - $2.11 Million
36,418 Added 1.8%
2,063,704 $359 Million
Q2 2018

Aug 15, 2018

SELL
$42.45 - $51.3 $1.21 Million - $1.46 Million
-28,448 Reduced 1.38%
2,027,286 $295 Million
Q1 2018

May 17, 2018

SELL
$37.19 - $47.45 $2.25 Million - $2.87 Million
-60,385 Reduced 2.85%
2,055,734 $287 Million
Q4 2017

Feb 15, 2018

BUY
$33.79 - $39.39 $394,498 - $459,878
11,675 Added 0.55%
2,116,119 $239 Million
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $76.4 Million - $81.7 Million
2,104,444
2,104,444 $230 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Disciplined Growth Investors Inc Portfolio

Follow Disciplined Growth Investors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Disciplined Growth Investors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Disciplined Growth Investors Inc with notifications on news.